BIOMAT Database Logo BIOMAT Database Logo

Steroids and immunosuppression. Effect on anastomotic intimal hyperplasia in femoral arterial dacron bypass grafts. 1979

L M Hoepp, and A Elbadawi, and M Cohn, and R Dachelet, and C Peterson, and J A DeWeese

The effects of steroids and immunosuppression on 6-cm long bilateral femoral arterial Dacron bypass grafts were studied in 30 adult mongrel dogs. The dogs were serially placed into one of the following three groups: control, steroid, and immunosuppression. The control and steroid groups each had a 70% graft patency rate, whereas the immunosuppression group had a 100% eight-week graft patency rate. The results in the steroid group were not statistically different from the control group, whereas the results in the immunosuppression group were statistically different from the control. The decrease in internal diameter was secondary to a localized accumulation of tissue at the anastomotic site, which histologically appeared to be a hyperplastic intima morphologically different in each group. There is a substantial decrease in intimal hyperplasia at anastomotic sites and a higher graft patency rate in dogs treated with low-dose azathioprine as compared with control of steroid-treated animals. The mechanism seems to be a slower and more orderly intimalization rather than suppression of any specific intimal cellular elements.

UI MeSH Term Description Entries
D006965 Hyperplasia An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells. Hyperplasias
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D008775 Methylprednisolone A PREDNISOLONE derivative with similar anti-inflammatory action. 6-Methylprednisolone,Medrol,Metipred,Urbason,6 Methylprednisolone
D011093 Polyethylene Terephthalates Polyester polymers formed from terephthalic acid or its esters and ethylene glycol. They can be formed into tapes, films or pulled into fibers that are pressed into meshes or woven into fabrics. Dacron,Nalophan,PET Polymer,Poly(Ethylene Terephtalate),Polyethylene Terephthalate,Tedlar,Dacrons,Nalophans,PET Polymers,Tedlars,Terephthalate, Polyethylene,Terephthalates, Polyethylene
D001807 Blood Vessel Prosthesis Device constructed of either synthetic or biological material that is used for the repair of injured or diseased blood vessels. Vascular Prosthesis,Blood Vessel Prostheses,Tissue-Engineered Vascular Graft,Graft, Tissue-Engineered Vascular,Grafts, Tissue-Engineered Vascular,Prostheses, Blood Vessel,Prostheses, Vascular,Prosthesis, Blood Vessel,Prosthesis, Vascular,Tissue Engineered Vascular Graft,Tissue-Engineered Vascular Grafts,Vascular Graft, Tissue-Engineered,Vascular Grafts, Tissue-Engineered,Vascular Prostheses,Vessel Prostheses, Blood,Vessel Prosthesis, Blood
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D005263 Femoral Artery The main artery of the thigh, a continuation of the external iliac artery. Common Femoral Artery,Arteries, Common Femoral,Arteries, Femoral,Artery, Common Femoral,Artery, Femoral,Common Femoral Arteries,Femoral Arteries,Femoral Arteries, Common,Femoral Artery, Common
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001379 Azathioprine An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed) Azathioprine Sodium,Azathioprine Sodium Salt,Azathioprine Sulfate,Azothioprine,Immuran,Imuran,Imurel,Sodium, Azathioprine
D013927 Thrombosis Formation and development of a thrombus or blood clot in BLOOD VESSELS. Atherothrombosis,Thrombus,Blood Clot,Blood Clots,Thromboses

Related Publications

L M Hoepp, and A Elbadawi, and M Cohn, and R Dachelet, and C Peterson, and J A DeWeese
Compliance and formation of distal anastomotic intimal hyperplasia in Dacron mesh tube constricted veins used as arterial bypass grafts.
January 1994, ASAIO journal (American Society for Artificial Internal Organs : 1992),
L M Hoepp, and A Elbadawi, and M Cohn, and R Dachelet, and C Peterson, and J A DeWeese
Quantitative analysis of anastomotic intimal hyperplasia in paired Dacron and PTFE grafts.
January 1989, The Journal of cardiovascular surgery,
L M Hoepp, and A Elbadawi, and M Cohn, and R Dachelet, and C Peterson, and J A DeWeese
Downstream anastomotic hyperplasia. A mechanism of failure in Dacron arterial grafts.
April 1983, Annals of surgery,
L M Hoepp, and A Elbadawi, and M Cohn, and R Dachelet, and C Peterson, and J A DeWeese
Intimal hyperplasia and hemodynamic factors in arterial bypass and arteriovenous grafts: a review.
January 2003, Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs,
L M Hoepp, and A Elbadawi, and M Cohn, and R Dachelet, and C Peterson, and J A DeWeese
Effect of aspirin on intimal hyperplasia and cholesterol uptake in experimental bypass grafts.
March 1991, The Canadian journal of cardiology,
L M Hoepp, and A Elbadawi, and M Cohn, and R Dachelet, and C Peterson, and J A DeWeese
Intimal hyperplasia in autogenous vein grafts used for arterial bypass: a canine model.
September 1985, Cardiovascular research,
L M Hoepp, and A Elbadawi, and M Cohn, and R Dachelet, and C Peterson, and J A DeWeese
Effects of cod-liver oil on intimal hyperplasia in vein grafts used for arterial bypass.
March 1986, Canadian journal of surgery. Journal canadien de chirurgie,
L M Hoepp, and A Elbadawi, and M Cohn, and R Dachelet, and C Peterson, and J A DeWeese
Dacron femoral-popliteal bypass grafts in good-risk claudicant patients.
May 2004, American journal of surgery,
L M Hoepp, and A Elbadawi, and M Cohn, and R Dachelet, and C Peterson, and J A DeWeese
In vitro studies on anastomotic intimal hyperplasia.
January 1997, ASAIO journal (American Society for Artificial Internal Organs : 1992),
L M Hoepp, and A Elbadawi, and M Cohn, and R Dachelet, and C Peterson, and J A DeWeese
Effect of anastomotic length on the development of intimal hyperplasia in the distal anastomosis of bypass graft.
January 2010, Vascular,
Copied contents to your clipboard!